In the wake of the Scandinavian Simvastatin Survival Study trial

After becoming generic, statins are inexpensive and well tolerated therapy with potential to substantially reduce the burden of atherosclerotic vascular disease world-wide. To achieve these goals, both accessibility and adherence are fundamental issues.

Authors

Institutions

Publication Details

Journal
Current Opinion in Lipidology
Published
2025-08-12
DOI
https://doi.org/10.1097/mol.0000000000001008
Citations
1
Primary Topic
Lipoproteins and Cardiovascular Health
Type
article
Field-Weighted Citation Impact
2.01
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

In the wake of the Scandinavian Simvastatin Survival Study trial

Timo Strandberg
1 citations
Current Opinion in Lipidology
Lipoproteins and Cardiovascular Health
2.01
article

In the wake of the Scandinavian Simvastatin Survival Study trial

Timo Strandberg
article en
1 citations

Abstract

After becoming generic, statins are inexpensive and well tolerated therapy with potential to substantially reduce the burden of atherosclerotic vascular disease world-wide. To achieve these goals, both accessibility and adherence are fundamental issues.

Current Opinion in LipidologyVol. 36(6)
University of Helsinki (FI), Helsinki University Hospital (FI), University of Oulu (FI)
Openalex Percentile: Top 13%
Lipoproteins and Cardiovascular Health
2.01
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.